JPS6379874A - Isoindole derivative - Google Patents

Isoindole derivative

Info

Publication number
JPS6379874A
JPS6379874A JP22515886A JP22515886A JPS6379874A JP S6379874 A JPS6379874 A JP S6379874A JP 22515886 A JP22515886 A JP 22515886A JP 22515886 A JP22515886 A JP 22515886A JP S6379874 A JPS6379874 A JP S6379874A
Authority
JP
Japan
Prior art keywords
formula
compound
group
reacting
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP22515886A
Other languages
Japanese (ja)
Other versions
JPH07116143B2 (en
Inventor
Masayuki Kitagawa
北川 正之
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP22515886A priority Critical patent/JPH07116143B2/en
Publication of JPS6379874A publication Critical patent/JPS6379874A/en
Publication of JPH07116143B2 publication Critical patent/JPH07116143B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

NEW MATERIAL:The compound of formula I (R<1> is H,lower alkyl, aryl, aralkyl, etc.; X is H or halogen; Y is carboxyl, tetrazolyl, etc.; n is 1-6). EXAMPLE:Ethyl [(7-chloro-2,3-dihydro-1-oxo-2-phenyl-1H-isoindol-5-yl)oxy]acetate. USE:Remedy for hypertension, etc., having diuretic and hypotensive activities accompanying salt-excreting action. PREPARATION:The compound of formula I can be produced by reacting the compound of formula II (R<2> and R<3> are lower alkyl) with a halogenation reagent such as N-bromosuccinimide in the presence of a radical generator such as perbenzoic acid, etc., and reacting the reaction product with a primary amine of formula R<1>NH2. The reaction is carried out in a nonpolar organic solvent such as carbon tetrachloride at room temperature - 120 deg.C.

Description

【発明の詳細な説明】 本発明は一般式(I) (式中、R1は水素原子、低級アルキル基、環状アルキ
ル基、アリール基、又はアルアルキル基を示し、該環状
アルキル基、アリール基及びアルアルキル基は1個以上
の置換基を有していてもよい。Xは水素原子又はハロゲ
ン原子を示す。Yはカルボキシル基、低級アルコキシカ
ルボニル基又はテトラゾリル基を示す、nは1〜6の整
数を示す、)で表わされる化合物及びその塩に関する。
Detailed Description of the Invention The present invention relates to the general formula (I) (wherein R1 represents a hydrogen atom, a lower alkyl group, a cyclic alkyl group, an aryl group, or an aralkyl group, and the cyclic alkyl group, aryl group and The aralkyl group may have one or more substituents. ) and its salts.

〈産業上の利用分野〉 本発明の化合物は、塩類排泄を伴う利尿作用を有し、高
血圧症等の治療薬として有用である。
<Industrial Application Field> The compound of the present invention has a diuretic effect accompanied by salt excretion, and is useful as a therapeutic agent for hypertension and the like.

〈従来の技術〉 従来、利尿降圧剤としては、サイアザイド系の薬剤、ス
ピロノラクトン、フロセミド等が知られている。しかし
、これらの薬剤のうちイソインドール骨格を有するもの
は知られていない。
<Prior Art> As diuretic antihypertensive agents, thiazide drugs, spironolactone, furosemide, and the like are conventionally known. However, none of these drugs have an isoindole skeleton.

〈発明の構成〉 本発明は式(1)の化合物及びその塩に関する。<Structure of the invention> The present invention relates to compounds of formula (1) and salts thereof.

式(I)において低級アルキル基としては、メチル、エ
チル、プロピル、イソプロピル、ローブチル、等三級ブ
チル、等をあげることができる。環状アルキル基として
は、シクロプロピル、シクロブチル、シクロペンチル、
シクロヘキシル等があげられる。アリール基としては、
フェニル、ナフチル、ビフェニル等があげられる。アル
キル基としては、ベンジル、フェニルエチル、フェニル
プロピル、ナフチルメチル、ナフチルエチル、ビフェニ
ルメチル等があげられる。環状アルキル基、アリール基
及びアルアルキル基が有してもよい置換基としては、水
酸基、ハロゲン原子、低級アルキル基、低級アルコキシ
ル基、トリフルオロメチル基等をあげることができる。
Examples of the lower alkyl group in formula (I) include methyl, ethyl, propyl, isopropyl, lobutyl, and tertiary butyl. Cyclic alkyl groups include cyclopropyl, cyclobutyl, cyclopentyl,
Examples include cyclohexyl. As an aryl group,
Examples include phenyl, naphthyl, and biphenyl. Examples of the alkyl group include benzyl, phenylethyl, phenylpropyl, naphthylmethyl, naphthylethyl, biphenylmethyl, and the like. Examples of substituents that the cyclic alkyl group, aryl group, and aralkyl group may have include a hydroxyl group, a halogen atom, a lower alkyl group, a lower alkoxyl group, and a trifluoromethyl group.

上記環状アルキル基、アリール基及びアルアルキル基が
二個以上の置換基を有する場合には、これらの置換基は
同じ又は異ってもよい、ハロゲン原子としては、フッ素
、塩素、臭素及びヨウ素があげられる。
When the above-mentioned cyclic alkyl group, aryl group and aralkyl group have two or more substituents, these substituents may be the same or different. Examples of the halogen atom include fluorine, chlorine, bromine and iodine. can give.

式(1)の化合物の塩としては、Yがカルボキシル基又
はテトラゾリル基である場合そのナトリウム塩、カリウ
ム塩、カルシウム塩、マグネシウム塩等のアルカリ金属
塩、アルカリ土類金属塩、アンモニウム塩等の無機塩基
との塩及びN−メチルグルカミン塩、エタノールアミン
塩等の有機塩基との塩をあげることがでとる。
When Y is a carboxyl group or a tetrazolyl group, salts of the compound of formula (1) include inorganic salts such as alkali metal salts such as sodium salts, potassium salts, calcium salts, and magnesium salts, alkaline earth metal salts, and ammonium salts. Examples include salts with bases and salts with organic bases such as N-methylglucamine salt and ethanolamine salt.

本発明の化合物は、種々の製造法により製造可能であり
、以下にその例を示す。
The compound of the present invention can be produced by various production methods, examples of which are shown below.

a) (式中、R2及びR3はそれぞれ低級アルキル基を示し
、X、R’及びnは前記に同じ)式(11)の化合物を
過安息香酸等のラジカル発生剤存在下N−プロモサクシ
ンイミド等のハロゲン化試薬と反応、せしめた後、式(
III )で表わされる一級アミンと反応させることに
より式(I a)の化合物を製造することができる。溶
媒としては、非極性有機溶媒が使用可能であり、例えば
四塩化炭素等が好ましい、−級アミンの量は通常式(I
I)で表わされる化合物に比して2〜20倍程度でよい
0反応温度は通常室温乃至約120℃の間で適宜選択さ
れる。
a) (In the formula, R2 and R3 each represent a lower alkyl group, and X, R' and n are the same as above) A compound of formula (11) is converted to N-promosuccinimide in the presence of a radical generator such as perbenzoic acid. After reacting with a halogenating reagent such as
The compound of formula (Ia) can be produced by reacting with a primary amine represented by III). As the solvent, non-polar organic solvents can be used, preferably carbon tetrachloride, etc. The amount of the -class amine is usually determined by the formula (I
The reaction temperature, which may be about 2 to 20 times that of the compound represented by I), is usually appropriately selected from room temperature to about 120°C.

b) (式中、X、R’ 、R3及びnは前記に同じであり、
Aはハロゲン原子を示す、) 式(rV)で表わされる化合物を不活性溶媒中式(V)
の化合物と塩基の存在下反応させることにより、式(I
a)の化合物を製造することができる。不活性溶媒とし
ては、ジメチルホルムアミド、アセトン等があげられる
。塩基としては、アルカリ金属の炭酸塩などが好ましく
、具体的には炭酸カリウム、炭酸ナトリウム等を挙げる
ことができる。反応温度は室温乃至約100℃の間で適
宜選択される。
b) (wherein X, R', R3 and n are the same as above,
A represents a halogen atom) A compound represented by formula (rV) is converted to formula (V) in an inert solvent.
By reacting with a compound of formula (I) in the presence of a base, the compound of formula (I
The compound of a) can be produced. Examples of the inert solvent include dimethylformamide and acetone. The base is preferably an alkali metal carbonate, and specific examples include potassium carbonate and sodium carbonate. The reaction temperature is appropriately selected between room temperature and about 100°C.

CIA)           (II))(式中、X
、R’、R’及びnは前記に同じ)式(Ia )の化合
物を水もしくはメタノール、エタノール、ジオキサン、
ジメチルホルムアミド等の有機溶媒と水との混合溶媒中
、アルカリ金属又はアルカリ土類金属の水酸化物等の塩
基と反応させる事により、式(Ib)で表わされる化合
物を製造する事ができる。
CIA) (II)) (wherein, X
, R', R' and n are the same as above) The compound of formula (Ia) is mixed with water, methanol, ethanol, dioxane,
A compound represented by formula (Ib) can be produced by reacting with a base such as an alkali metal or alkaline earth metal hydroxide in a mixed solvent of an organic solvent such as dimethylformamide and water.

上記式(It )の原料化合物は以下に示す方法により
製造することができる。
The raw material compound of formula (It) above can be produced by the method shown below.

(■)      (m)      (■)(■) 
               (正)(式中、X、R
’、及びR3は前記に同じ)即ち、式(mV)の化合物
を通常のエステル化反応、例えば、チオニルクロリドと
反応させた後、低級アルコールと反応させることにより
式(■)の化合物とすることができる。次に式(■)の
化合物を酢酸エチルエステルのような不活性有機溶媒に
溶解し、パラジウム−炭素存在下接触還元に付すことに
より式(■)の化合物を得ることができる。続いて式(
■)の化合物を硫酸酸性下、亜硝酸ナトリウムと反応し
、ジアゾ化した後、加水分解することにより式(IX)
の化合物を得ることができる。式(IX)の化合物をジ
メチルホルムアミド又はアセトン中に溶解し、炭酸カリ
ウムのようなアルカリ金属の炭酸塩と、室温乃至 10
0 ’eの温度で反応させることにより、式(II)の
化合物を得ることができる。尚、式(Vl)の化合物は
公知の方法(J、Med、chem、、241337−
1342(1981))を参照して製造することができ
る。
(■) (m) (■) (■)
(Correct) (In the formula, X, R
', and R3 are the same as above) That is, the compound of formula (mV) is reacted with a normal esterification reaction, for example, with thionyl chloride, and then reacted with a lower alcohol to form the compound of formula (■). Can be done. Next, the compound of formula (■) can be obtained by dissolving the compound of formula (■) in an inert organic solvent such as ethyl acetate and subjecting it to catalytic reduction in the presence of palladium and carbon. Then the formula (
The compound of formula (IX) is reacted with sodium nitrite under sulfuric acid acidity, diazotized, and then hydrolyzed.
can be obtained. A compound of formula (IX) is dissolved in dimethylformamide or acetone and mixed with an alkali metal carbonate such as potassium carbonate at room temperature to 10
By reacting at a temperature of 0'e, a compound of formula (II) can be obtained. The compound of formula (Vl) can be prepared by a known method (J, Med, chem, 241337-
1342 (1981)).

又、式(■)の原料化合物は以下に示す方法により製造
することができる。
Further, the raw material compound of formula (■) can be produced by the method shown below.

(式中、X、R’、及びR2は前記に同じ)即ち、式(
IX)の化合物をアセトン又はジメチルホルムアミドの
ような不活性有機溶媒中、無水炭酸カリウム存在下ヨー
ドメチルと反応させることにより式(X)の化合物を製
造することができる。続いて式(X)の化合物を四塩化
炭素に溶解し、過安息香酸存在下、N−プロモサクシン
イミドと反応し、ブロム化した後、式(III )で表
わされる一級アミンと室温乃至120℃の温度で反応さ
せることにより式(XI)の化合物を得ることができる
0次に式(XI)の化合物を通常の脱メチル化反応、例
えばベンゼンのような不活性有機溶媒中、無水塩化アル
ミニウムを加え還流することにより式(mV)の化合物
を製造することができる。
(In the formula, X, R', and R2 are the same as above) That is, the formula (
Compounds of formula (X) can be prepared by reacting compounds of formula (IX) with iodomethyl in the presence of anhydrous potassium carbonate in an inert organic solvent such as acetone or dimethylformamide. Subsequently, the compound of formula (X) is dissolved in carbon tetrachloride, reacted with N-promosuccinimide in the presence of perbenzoic acid, brominated, and then treated with a primary amine represented by formula (III) from room temperature to 120°C. Compounds of formula (XI) can be obtained by reacting the compounds of formula (XI) at a temperature of By adding and refluxing, a compound of formula (mV) can be produced.

〈発明の効果〉 本発明の化合物は塩類排泄作用を伴う利尿及び降圧作用
にすぐれており医薬として有用な化合物である。
<Effects of the Invention> The compound of the present invention has excellent diuretic and antihypertensive effects accompanied by salt excretion, and is a useful compound as a medicine.

以下に本発明化合物の有する薬理作用を具体的に示す。The pharmacological effects of the compounds of the present invention are specifically shown below.

利尿及び塩類排泄作用 実験前日より絶食した雄性ラット(体重150〜zso
g)に経口ゾンデにより生理食塩液の経口負荷(25m
A/kg)を行い、引き続きO9詰カルボキシメチルセ
ルロースに懸濁した試験化合物を経口投与した。投与5
時間後、尿量及び尿中ナトリウム排泄量を測定した。対
照群の動物には0.5*カルボキシメチルセルロースの
みを経口投与した。
Diuretic and salt excretion effects Male rats (body weight 150 ~ zso) were fasted from the day before the experiment.
g) Oral loading of physiological saline (25 m
A/kg), and then the test compound suspended in O9 packed carboxymethyl cellulose was orally administered. Administration 5
After a period of time, urine volume and urinary sodium excretion were measured. Animals in the control group received 0.5*carboxymethylcellulose alone orally.

結果を表1に示した。The results are shown in Table 1.

表1 * p< o、os、  傘* p< 0.01.  
VS対照群尚、表1の尿量及び尿中Na量は以下の式に
より算出した。
Table 1 * p < o, os, umbrella * p < 0.01.
VS control group The urine volume and urinary Na content in Table 1 were calculated using the following formula.

尿量=(試験化合物群の尿量) −(対照群の尿量) 尿中Na量=(試験化合物投与群の尿中Na量)−(対
照群の尿中Na量) 表1から明らかなように本発明の化合物は対照化合物で
あるチェニル酸に比べ優れた利尿及び塩類排泄作用を示
した。
Urine volume = (Urine volume of test compound group) - (Urine volume of control group) Urinary Na content = (Urine Na content of test compound administration group) - (Urine Na content of control group) It is clear from Table 1 As shown, the compound of the present invention exhibited superior diuretic and salt excretion effects compared to the control compound, chenilic acid.

化合物a−cを以下に示す。Compounds a-c are shown below.

化合物a〔(7−クロロ−2,3−ジヒドロ−1−オキ
更に本発明を参考例及び実施例により説明するが、本発
明は、これらによって限定されるものではない。
Compound a [(7-chloro-2,3-dihydro-1-oxy) The present invention will be further explained with reference to Reference Examples and Examples, but the present invention is not limited thereto.

参考例1 工程1 メチル 2−クロロ−6−メチル−4−二トロ
ベンゾエート 2−クロロ−6−メチル−4−ニトロ安息香酸19.5
gをチオニルクロリド180mfL中に溶解し、2時間
速流した。過剰のチオニルクロリドを減圧下留去した後
、得られた油状物をメタノール200mλ中に溶解し、
4.5時間速流した0反応液を濃縮し、針状晶を得た。
Reference Example 1 Step 1 Methyl 2-chloro-6-methyl-4-nitrobenzoate 2-chloro-6-methyl-4-nitrobenzoic acid 19.5
g was dissolved in 180 mfL of thionyl chloride and fast-flowed for 2 hours. After distilling off excess thionyl chloride under reduced pressure, the obtained oil was dissolved in 200 mλ of methanol,
The 0 reaction solution, which was rapidly flowed for 4.5 hours, was concentrated to obtain needle-shaped crystals.

メタノールより再結晶し白色針状晶として標記化合物を
17.9g得た。融点90−92℃工程2 メチル 4
−アミノ−2−クロロ−6−メチルベンゾエート 工程1で得られた化合物31.4gを酢酸エチルエステ
ル500mIL中に溶解し、酸化白金0.8gを加えて
接解還元に付した。理論量の水素を吸収させた後、触媒
を濾過し、溶媒を減圧下留去した。残渣を少量のエーテ
ルに溶解し、不溶物を濾過した。
Recrystallization from methanol gave 17.9 g of the title compound as white needle-like crystals. Melting point 90-92℃ Step 2 Methyl 4
-Amino-2-chloro-6-methylbenzoate 31.4 g of the compound obtained in Step 1 was dissolved in 500 mL of ethyl acetate, and 0.8 g of platinum oxide was added thereto for catalytic reduction. After absorbing the theoretical amount of hydrogen, the catalyst was filtered and the solvent was distilled off under reduced pressure. The residue was dissolved in a small amount of ether, and insoluble materials were filtered.

濾液中のエーテルを留去し、淡黄色結晶として標記化合
物を26.6g得た。融点74−77℃工程2で得られ
た化合物98gを1韓硫酸2.5文中に、60〜70℃
に加温しながら溶解した。同温度下、反応液中に亜硝酸
ナトリウム水溶液(亜硝酸ナトリウム37.3g、水3
00mfL)を少量ずつ滴下し、終了後さらに1時間攪
拌した。放冷後反応液中にベンゼンを加えて抽出した。
The ether in the filtrate was distilled off to obtain 26.6 g of the title compound as pale yellow crystals. Melting point 74-77℃ 98g of the compound obtained in step 2 was added to 2.5 grams of 1-K sulfuric acid at 60-70℃.
It was dissolved while heating. At the same temperature, a sodium nitrite aqueous solution (sodium nitrite 37.3 g, water 3
00 mfL) was added dropwise little by little, and after the completion of the addition, the mixture was further stirred for 1 hour. After cooling, benzene was added to the reaction mixture for extraction.

ベンゼン層を芒硝にて乾燥後、ベンゼンを留去し、残漬
をシリカゲルカラムクロマトに付し黄色結晶として標記
化合物を77g得た。
After drying the benzene layer with Glauber's salt, the benzene was distilled off, and the residue was subjected to silica gel column chromatography to obtain 77 g of the title compound as yellow crystals.

工程3で得た化合物16.3gをジメチルホルムアミド
340m1中に溶解し、無水炭酸カリウム16.8g。
16.3 g of the compound obtained in step 3 was dissolved in 340 ml of dimethylformamide, and 16.8 g of anhydrous potassium carbonate.

エチルブロムアセテート20.3gを加え60〜70℃
に加温しながら5時間反応した。終了後、ジメチルホル
ムアミドを減圧下留去し、得られた残漬中に氷水を加え
、続いてエーテルを加え抽出した。ついでエーテル層を
水洗後、芒硝にて乾燥し、エーテルを減圧下留去した。
Add 20.3g of ethyl bromoacetate and 60-70℃
The reaction was continued for 5 hours while heating. After completion of the reaction, dimethylformamide was distilled off under reduced pressure, ice water was added to the resulting residue, and then ether was added for extraction. The ether layer was then washed with water, dried over sodium sulfate, and the ether was distilled off under reduced pressure.

得られた残渣をシリカゲルカラムクロマトに付して精製
し標記化合物を19.9g得た。
The obtained residue was purified by silica gel column chromatography to obtain 19.9 g of the title compound.

参考例2 参考例1の工程3で得られた化合物17.0gをアセト
ン200t+lに溶解し、無水炭酸カリウム12.9g
Reference Example 2 17.0 g of the compound obtained in Step 3 of Reference Example 1 was dissolved in 200 t+l of acetone, and 12.9 g of anhydrous potassium carbonate was dissolved.
.

ヨウ化メチル13.3gを加え4時間加熱還流した。13.3 g of methyl iodide was added and the mixture was heated under reflux for 4 hours.

放冷し不溶物を濾過後、濾液を減圧下濃縮乾固し、残漬
をシリカゲルカラムクロマトに付し淡黄色油状物として
標記化合物を14.0g得た。
After cooling and filtering off insoluble materials, the filtrate was concentrated to dryness under reduced pressure, and the residue was subjected to silica gel column chromatography to obtain 14.0 g of the title compound as a pale yellow oil.

ドール 工程1で得た化合物12.0gをベンゼン250+nI
L中に溶解し、N−プロモサクシンイミド10.7g 
、過酸化ベンゾイル0.5gを加え3時間加熱還流した
。放冷後、析出した結晶を濾去し濾液中にオルトトルイ
ジン12gを加え6時間加熱還流した。放冷後希塩酸中
に反応液を注ぎ、酢酸エチルエステルにて抽出した。有
機層を芒硝にて乾燥後、溶媒を留去し、得られた残渣を
エタノールから再結晶し、標記化合物を7.1g得た。
12.0 g of the compound obtained in Dole step 1 was added to 250 nI of benzene.
10.7 g of N-promosuccinimide dissolved in L
, 0.5 g of benzoyl peroxide was added, and the mixture was heated under reflux for 3 hours. After cooling, the precipitated crystals were filtered off, 12 g of orthotoluidine was added to the filtrate, and the mixture was heated under reflux for 6 hours. After cooling, the reaction solution was poured into dilute hydrochloric acid and extracted with ethyl acetate. After drying the organic layer over Glauber's salt, the solvent was distilled off, and the resulting residue was recrystallized from ethanol to obtain 7.1 g of the title compound.

融点171.5−172.5℃ンドール 工程2で得られた化合物7.0gをベンゼン200m1
中に溶解し、無水塩化アルミニウム6.5gを加え、3
時間還流した。玲後減圧下溶媒を留去し、残漬に希塩酸
を加え30分攪拌した。析出した結晶を濾取し熱水にて
十分洗浄した後乾燥して、標記化合物を8.8g得た。
Melting point: 171.5-172.5℃
Add 6.5 g of anhydrous aluminum chloride,
Refluxed for an hour. After that, the solvent was distilled off under reduced pressure, diluted hydrochloric acid was added to the residue, and the mixture was stirred for 30 minutes. The precipitated crystals were collected by filtration, thoroughly washed with hot water, and then dried to obtain 8.8 g of the title compound.

融点272−273℃参考例2と同様にして以下の参考
例3〜6の化合物を得た。
Melting point: 272-273°C Compounds of Reference Examples 3 to 6 below were obtained in the same manner as Reference Example 2.

実施例1 参考例1で得た化合物19.3gを四塩化炭素500v
aiL中に溶解し、N−プロモサクシンイミド12.3
g。
Example 1 19.3g of the compound obtained in Reference Example 1 was heated with 500v of carbon tetrachloride.
Dissolved in aiL, N-promosuccinimide 12.3
g.

過酸化ベンゾイル100mgを加え6時間還流した。100 mg of benzoyl peroxide was added and the mixture was refluxed for 6 hours.

放冷後、不溶物をろ過し、濾液中にアニリン64.3g
を加え、室温下1時間攪拌後90〜100℃の温度で2
時間反応した。反応液を放冷後、4N−塩酸を加え洗浄
することによって過剰のアニリンを除去した。有機層を
水洗し、芒硝にて乾燥後、溶媒を留去した。得られた残
漬をシリカゲルカラムクロマトにて精製した後、エタノ
ールから再結晶して、標記化合物を4.3g得た。融点
150−152℃実施例1と同様にして以下の実施例2
〜6の化合物を得た。
After cooling, insoluble matter was filtered, and 64.3 g of aniline was found in the filtrate.
was added, stirred at room temperature for 1 hour, and then stirred at a temperature of 90 to 100°C for 2 hours.
Time reacted. After the reaction solution was allowed to cool, excess aniline was removed by adding 4N hydrochloric acid and washing. The organic layer was washed with water, dried over Glauber's salt, and then the solvent was distilled off. The obtained residue was purified by silica gel column chromatography and then recrystallized from ethanol to obtain 4.3 g of the title compound. Melting point: 150-152°C Similar to Example 1, the following Example 2
-6 compounds were obtained.

実施例7 参考例2で得られた化合物6.8gをアセトン200m
λに懸濁し、炭酸カリウム3.8g、エチルブロムアセ
テート4.57gを加え2時間還流した。放冷後反応液
をろ過し、濾液を減圧下濃縮乾固し、残漬をシリカゲル
カラムクロマトに付してyi製し、標記化合物を7.8
g得た。融点98−100℃実施例7と同様にして以下
の実施例8〜11の化合物を得た。
Example 7 6.8g of the compound obtained in Reference Example 2 was added to 200ml of acetone.
λ, 3.8 g of potassium carbonate and 4.57 g of ethyl bromoacetate were added, and the mixture was refluxed for 2 hours. After cooling, the reaction solution was filtered, the filtrate was concentrated to dryness under reduced pressure, and the residue was subjected to silica gel column chromatography to obtain a yield of 7.8%.
I got g. Melting point: 98-100°C In the same manner as in Example 7, the following compounds of Examples 8 to 11 were obtained.

実施例12 実施例1で得られた化合物4.2gをジメチルホルムア
ミド40mfL中に加温溶解した。この溶液中に水酸化
ナトリウム水溶液(水酸化ナトリウム1.46g、水1
5IIIA )を少量ずつ加えた。室温下1時間攪拌し
た後、反応液を350mjlの水中に注ぎ、ついで濃塩
酸を加えて酸性とし、析出物を濾取し標記化合物を3.
2g得た。融点207−209℃NMRδppm(DM
SO−da 、 TMS)4.82(2H,S) 4.87(2H,s) 7.0〜7.15(2H) 7.15〜7.77 (5H,m) 実施例12と同様にして以下の実施例13〜22の化合
物を得た。
Example 12 4.2 g of the compound obtained in Example 1 was dissolved under heating in 40 mfL of dimethylformamide. Add to this solution a sodium hydroxide aqueous solution (sodium hydroxide 1.46 g, water 1
5IIIA) was added little by little. After stirring at room temperature for 1 hour, the reaction solution was poured into 350 mjl of water, then made acidic by adding concentrated hydrochloric acid, and the precipitate was collected by filtration to obtain the title compound.
I got 2g. Melting point 207-209℃ NMR δppm (DM
SO-da, TMS) 4.82 (2H, S) 4.87 (2H, s) 7.0 to 7.15 (2H) 7.15 to 7.77 (5H, m) Same as Example 12 The following compounds of Examples 13 to 22 were obtained.

手続補正書Procedural amendment

Claims (1)

【特許請求の範囲】 一般式 ▲数式、化学式、表等があります▼ (式中、R^1は水素原子、低級アルキル基、環状アル
キル基、アリール基、又はアルアルキル基を示し、該環
状アルキル基、アリール基及びアルアルキル基は1個以
上の置換基を有していてもよい。Xは水素原子又はハロ
ゲン原子を示す。Yはカルボキシル基、低級アルコキシ
カルボニル基又はテトラゾリル基を示す。nは1〜6の
整数を示す。)で表わされる化合物及びその塩
[Claims] General formula▲ Numerical formula, chemical formula, table, etc.▼ (In the formula, R^1 represents a hydrogen atom, a lower alkyl group, a cyclic alkyl group, an aryl group, or an aralkyl group; The group, aryl group and aralkyl group may have one or more substituents. X represents a hydrogen atom or a halogen atom. Y represents a carboxyl group, a lower alkoxycarbonyl group or a tetrazolyl group. n is (indicates an integer from 1 to 6) and its salts
JP22515886A 1986-09-24 1986-09-24 Isoindole derivative Expired - Lifetime JPH07116143B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP22515886A JPH07116143B2 (en) 1986-09-24 1986-09-24 Isoindole derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22515886A JPH07116143B2 (en) 1986-09-24 1986-09-24 Isoindole derivative

Publications (2)

Publication Number Publication Date
JPS6379874A true JPS6379874A (en) 1988-04-09
JPH07116143B2 JPH07116143B2 (en) 1995-12-13

Family

ID=16824850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP22515886A Expired - Lifetime JPH07116143B2 (en) 1986-09-24 1986-09-24 Isoindole derivative

Country Status (1)

Country Link
JP (1) JPH07116143B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives

Also Published As

Publication number Publication date
JPH07116143B2 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
JPH0329791B2 (en)
JPH0314315B2 (en)
JPH0681750B2 (en) Benzopyran derivative
JPH02138266A (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidine dione derivative
JPS6140234B2 (en)
JPH0331264A (en) Benzimidazole derivatives
SU1340585A3 (en) Method of producing derivatives of tetrazole
JPS6379874A (en) Isoindole derivative
IE883136L (en) Ó(2)-adreno receptor antagonists
JPS5825677B2 (en) 3-tetrazole-1-azaxanthone derivative and method for producing the same
US4420487A (en) Diuretic and antihypertensive benzimidazoles
JPS6127977A (en) 4,5-dihydro-3,3-diphenyl-4-hydrocarbyl aminomethylfuran-2(3h)-one
JPH0140833B2 (en)
JPH08176150A (en) Production of 5-chloro-4-(2-imidazolin-2-ylamino)-2,1,3-benzothiadiazole or its salt
JPS5942677B2 (en) 100% free of charge
JPS603376B2 (en) Chalcone derivative and its manufacturing method
JPH0250904B2 (en)
JPS62201861A (en) Amimophenol derivative
JPS6383089A (en) Furobenzopyran derivative
JPH013187A (en) Pyrazolo[1,5-a]-1,3,5-benzotriazepine compounds
JPS6043067B2 (en) 2-Alkoxyindolizine derivatives and their production method
JPS61268688A (en) Production of 2,6-diaminobenzo-(1,2-d:4,5-d&#39;)-bisthiazole
JPS60246384A (en) Chromone-8-carboxamide derivative
JPH02138281A (en) 3-substituted pyridobenzoxazine
JPS62209054A (en) Fluorodinitrobenzene derivative and production thereof